Literature DB >> 18097766

The role of the neuropeptide galanin in forming type-specific behavioral characteristics.

V I Lyudyno1, I N Abdurasulova, V M Klimenko.   

Abstract

Intranasal administration of a galanin receptor blocker to rats was found to change their behavioral type on being placed in an unfamiliar environment, with decreases in movement and investigative activity and increases in the level of anxiety in the open field test. The basal level of expression of the galanin precursor mRNA in the anterior hypothalamus was significantly higher in rats with the active type of behavior in the open field test. In conditions of galanin receptor blockade, there was also a faster increase in the serum corticosterone level in response to a stress situation (forced swimming test), which was accompanied by a reduction in the immobilization time. These data support the involvement of galanin in the formation of individual-typological behavioral characteristics and demonstrate its important role in adaptation to stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097766     DOI: 10.1007/s11055-008-0013-3

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  25 in total

Review 1.  Coping styles in animals: current status in behavior and stress-physiology.

Authors:  J M Koolhaas; S M Korte; S F De Boer; B J Van Der Vegt; C G Van Reenen; H Hopster; I C De Jong; M A Ruis; H J Blokhuis
Journal:  Neurosci Biobehav Rev       Date:  1999-11       Impact factor: 8.989

2.  [The stress phenomenon. Emotional stress and its role in pathology].

Authors:  M G Pshennikova
Journal:  Patol Fiziol Eksp Ter       Date:  2000 Apr-Jun

Review 3.  Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline.

Authors:  T Hökfelt; Z Q Xu; T J Shi; K Holmberg; X Zhang
Journal:  Ann N Y Acad Sci       Date:  1998-12-21       Impact factor: 5.691

4.  Galanin controls excitability of the brain.

Authors:  S A Chepurnov; N E Chepurnova; R K Berdiev
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

5.  Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders.

Authors:  M-C Pardon; G G Gould; A Garcia; L Phillips; M C Cook; S A Miller; P A Mason; D A Morilak
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 6.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

7.  Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat.

Authors:  S C Hooi; D M Maiter; J B Martin; J I Koenig
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

Review 8.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

9.  Corticotropin releasing factor and galanin-containing neurons projecting to the median eminence of the rat.

Authors:  M Niimi; J Takahara; K Kawanishi
Journal:  Neurosci Res       Date:  1992-09       Impact factor: 3.304

10.  [The open-field test as a prognostic criterion of resistance to emotional stress in Wistar rats].

Authors:  E V Koplik; R M Salieva; A V Gorbunova
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1995 Jul-Aug       Impact factor: 0.437

View more
  2 in total

1.  Neurochemical heterogeneity of rats predicted by different measures to be high ethanol consumers.

Authors:  Jessica R Barson; Shawn E Fagan; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

Review 2.  Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.

Authors:  Natale R Sciolino; Philip V Holmes
Journal:  Neurosci Biobehav Rev       Date:  2012-07-05       Impact factor: 8.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.